ArticleFrontiers in pharmacology2022

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity.

Dimitris K Karathanasis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.